Osaic Holdings’s IGM Biosciences IGMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-400
Closed -$508 8001
2025
Q3
$508 Hold
400
﹤0.01% 7549
2025
Q2
$448 Hold
400
﹤0.01% 7372
2025
Q1
$460 Buy
400
+304
+317% +$565 ﹤0.01% 7009
2024
Q4
$586 Buy
+96
New +$1.14K ﹤0.01% 6985
2024
Q3
Sell
-59
Closed -$405 7480
2024
Q2
$405 Buy
+59
New +$505 ﹤0.01% 7035
2022
Q2
Sell
-200
Closed -$5K 7460
2022
Q1
$5K Buy
200
+182
+1,011% +$3.39K ﹤0.01% 6478
2021
Q4
$1K Buy
18
+1
+6% +$50 ﹤0.01% 7192
2021
Q3
$1K Sell
17
-11
-39% -$842 ﹤0.01% 7026
2021
Q2
$2K Buy
28
+20
+250% +$1.48K ﹤0.01% 6708
2021
Q1
$1K Buy
8
+6
+300% +$546 ﹤0.01% 6660
2020
Q4
$0 Sell
2
-1
-33% -$70 ﹤0.01% 6479
2020
Q3
$0 Hold
3
﹤0.01% 6300
2020
Q2
$0 Buy
+3
New +$182 ﹤0.01% 6207

Osaic Holdings's IGMS Position: Q4 2025 in Review

Osaic Holdings sold out of IGM Biosciences (IGMS) in Q4 2025, closing a stake of 400 shares — an estimated $508 sold.

Osaic Holdings first reported a position in IGMS in Q2 2020 and held it in 13 quarters. The position peaked at $5K in Q1 2022. 0 funds tracked by Wall St. Rank hold IGMS as of Q4 2025.

  • Osaic Holdings reported no remaining IGM Biosciences position as of Q4 2025 after selling out during the quarter.
  • Osaic Holdings sold 400 IGM Biosciences shares in Q4 2025, an estimated $508.
  • Osaic Holdings first reported a position in IGM Biosciences in Q2 2020 and held it in 13 quarters.
  • Osaic Holdings's IGM Biosciences position peaked at $5K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held IGM Biosciences as of Q4 2025.

Based on Osaic Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.